Introducing Lifers: My New Podcast About the People Who Refuse to Quit on Healthcare
Hi everyone; Chrissy here.
I’m thrilled to share something I’ve been working on for months: my new podcast, Lifers.
For years, I’ve had some of the most honest, eye-opening conversations with founders, operators, clinicians, and policy leaders, often late at night, over texts, or in the corners of conferences. The kinds of conversations you never hear on the main stage.
I wanted a place for those conversations to live.
A place for real talk.
A place for the people who stay in healthcare long after logic says they shouldn’t.
That’s what Lifers is about: the operators, clinicians, and technologists who keep going, despite the setbacks, pivots, regulatory chaos, reimbursement nightmares, and decade-long timelines.
The ones who are still here — building, fixing, fighting, and trying to make healthcare better.
This is a new show, with a new tone, new format, and new energy. And I couldn’t be more excited to finally share it with you.
To kick things off, I sat down with an incredible lineup of guests and co-hosts:
- Michelle Carnahan – Arbiter
- Ari Hoffman, MD – Collective Health
- Graham Walker, MD – ER physician, MDCalc & Offcall
- Othman Laraki – CEO, Color Health
- Sam Holliday – CEO, Oshi Health
- V Bento – CEO, Sword Health
- Warris Bokhari – CEO, Claimable
- Mike Desjadon – CEO, Anomaly Health
These aren’t polished PR interviews. They’re the hard-won stories, unfiltered lessons, and behind-the-scenes realities of building in this space.
Throughout these conversations, there have been so many incredible moments of reflection that have stuck with me. Here are just a few:
“A drug is only hope in a bottle until it reaches a patient. That’s what keeps me here.”
Michelle Carnahan, on the moment she realized she’d never leave healthcare
“In big companies, the activity matters. In startups, the outcome matters.”
Warris Bokhari, on why he chose the hard path
“High-quality care is the cheapest care — because you actually get people better.”
V Bento, on incentives in healthcare
Subscribe wherever you listen
You can find Lifers on:
Or anywhere else you get your podcasts. Make sure to subscribe so new episodes download automatically, and enable notifications so you never miss a new one.
Tell me what you think
I’d love to know what topics you want me to cover next, who I should bring on, and what you want more of. Please also review my podcast; your reviews mean the world!
Lastly, if your company wants to sponsor an episode or season, reach out anytime at partnerships@secondopinion.media.
Thanks for listening, and for supporting this new chapter.
Upcoming Sessions
Live conversations with the people shaping healthcare.
Is It Finally the Moment for Alternative Plan Design?
Register Here Employers are under growing pressure to control healthcare costs while improving access, outcomes, and the member experience. That has renewed
Type 2 Diabetes & Cardiometabolic Care: Wearables, AI & GLP-1s
Register Here The rise of wearables, GLP-1s, and AI is reshaping treatment for Type 2 diabetes, weight loss, and metabolic disease.
Verifying AI in Medicine: Is Healthcare AI Actually Ready for Deployment?
Is AI ready for real-world clinical care? Dr. Zak Kohane and Protege’s Engy Ziedan debate what it takes to safely trust AI in diagnosis and treatment, from benchmark performance and clinical evidence to whether we’re holding AI to a higher standard than humans.
Why Are Hospitals Hiring Chief AI Officers?
As AI moves from pilots into day-to-day healthcare operations, health systems are having to decide who should actually own the
Where are AI Agents Actually Working in Healthcare, and Why?
While the healthcare industry remains locked in a high-level debate over the theoretical potential of artificial intelligence, a select group of
Top Employers Share What Healthcare Startups Need to Know in 2026
As enterprise health purchasers face volatile medical cost trends and tightening operational margins, the standard vendor pitch of "improved clinical efficiency&
Peptide Therapy: Where Do We Go From Here?
Watch the full webinar Peptide therapies have moved from niche biohacking circles into mainstream medicine, reshaping conversations around weight management, metabolic health,
Not everyone can access the top 1% of physicians. Will AI change that?
Historically, top-tier medical expertise was limited by wealth and geography. As AI reshapes healthcare delivery, a vital question emerges: can it democratize intelligence to give everyone access to the caliber of care typically reserved for the top 1%?
Privacy AI and the Future of HIPAA
Watch the Full Webinar As AI reshapes healthcare and more patient data flows beyond traditional clinical settings, the rules governing privacy, access,